Baker Avenue Asset Management, LP Teva Pharmaceutical Industries LTD Transaction History

Baker Avenue Asset Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $2,635 - $3,466	366 Added 1076.47%	400 $3,000
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $284 - $386	34 New	34 $0
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $384,254 - $743,901	-47,322 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $737,276 - $946,913	47,322 New	47,322 $742,000
Q3 2017 Nov 14, 2017	SELL	$15.41 - $32.17 $395,343 - $825,321	-25,655 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	25,655	25,655 $852,000

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $23.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.